Answers are grounded in this paper and cite their sources.
INTRODUCTION/AIM: Methods for counting epidermal neurite density (END), an objective biomarker for small-fiber neuropathy, are standardized, but laboratories' diagnostic algorithms defining Normal/Abnormal thresholds vary, permitting conflicting interpretations. Most laboratories lack norms for people < 20 years, precluding biopsy testing for them, and reporting units vary. Here we analyze these issues and develop a diagnostic algorithm that addresses them. METHODS: From 2000 to 2019 we obtained skin punches from the standard lower-leg sites of consented, screened healthy volunteers, including children ≥ 8 years, and performed standard bright-field PGP9.5 immunohistochemistry to generate a large, diverse dataset to analyze potentially contributory demographic factors to END-variability. We also analyzed results from 31 external healthy-END datasets to identify areas of inter-lab variability and targets for harmonization. RESULTS: Our 448-person dataset included 71 participants < 20 years. Their initially superabundant ENDs declined steeply in youth and shallowly thereafter. Thirty-one longitudinal sets of repeat biopsies corroborated our cross-sectional findings. We computationally modeled our dataset's significant age, sex, and race effects with initially single, then piecewise linear, and later logarithmic-linear fits to age. Among comparator studies, 81% also identified age declines, 53% reported lower male ENDs, and six studies of nominal race yielded conflicting conclusions. DISCUSSION: This unified pediatric/adult algorithm enables testing for childhood small-fiber neuropathy and may reduce false-negative interpretations for young adults. We generated seven quality-improvement suggestions for updating and harmonizing nomenclature, measurement-units, and algorithms. Setting consensus standards for normative datasets and algorithms might improve the quality and interoperability of skin-biopsy confirmation of small-fiber neuropathy and raise confidence in the validity of test results.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: